Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper .
Cohen
Adam L
AL
Divisions of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. dvj1@cdc.gov
Calfee
David
D
Fridkin
Scott K
SK
Huang
Susan S
SS
Jernigan
John A
JA
Lautenbach
Ebbing
E
Oriola
Shannon
S
Ramsey
Keith M
KM
Salgado
Cassandra D
CD
Weinstein
Robert A
RA
D002353:Carrier State / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D003428:Cross Infection / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D024901:Drug Resistance, Multiple, Bacterial; D016983:Enterococcus / Q000187:drug effects; D006090:Gram-Negative Bacteria / Q000187:drug effects; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D006801:Humans; D015994:Incidence; D016106:Methicillin Resistance; D011159:Population Surveillance / Q000379:methods; D015995:Prevalence; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects; D020713:Vancomycin Resistance